Gail M. Farfel
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gail M. Farfel
Gail M. Farfel is recorded as CEO at ProMIS Neurosciences Inc. (PMN). ProMIS Neurosciences Inc. reported in an 8-K filed September 13, 2022 that Gail M. Farfel was appointed Chief Executive Officer, effective September 19, 2022.
“ProMIS Neurosciences, Inc. (Nasdaq: PMN) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, announced today that it has appointed Gail M. Farfel, PhD, as Chief Executive Officer, effective September 19, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-19–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ProMIS Neurosciences Inc.
Other people whose current roles at this company are on record from its filings.
- Gail Farfel CEO
- Gail M. Farfel, PhD CEO
- Neil Warma CEO, Board Member
- Bill Wyman Board Member
- Eugene Williams Board Member
- Josh Mandel-Brehm Board Member
- Joshua Mandel-Brehm Board Member
- Maggie Shafmaster Board Member
- Maggie Shafmaster, Ph.D,J.D. Board Member
- Maggie Shafmaster, Ph.D., J.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.